We gathered speakers and attendees from Digital Pharma East to share their experience at this face to face event as well as share the highlights
The augmented and virtual reality industries are growing exponentially. Quite interestingly, the pharma industry has been quick to jump the bandwagon, using virtual reality to its advantage.
The stakes have never been higher for biotech, pharma, and medtech sales organizations. We explore ways that medical affairs, sales, and all customer-facing professionals can exceed the expectations of their customers and companies.
Nowadays, healthcare institutions are using electronic health records to manage information and capture data from patient appointments. Additionally, the data includes personal health records, reimbursement information, patient portals, and much more.
Delivering and Delighting HCP’s Everyone in the biopharmaceutical and MedTech space knows that customer-facing teammates need to win the attention of the health care professionals in order to convey the value proposition. Like most things in the life science industry, this is simple but not easy. Clearly the current times have strained the schedules of…
The Stakes Have Never Been Higher For The $1.3T Biopharmaceutical Industry The Covid-19 pandemic has changed how we live, and especially how we work. With a majority of the workforce around the world going remote, the pandemic has revealed the cracks in the processes workers and corporations have been using for so many years. It…
Eric Gubera, EVP of the Life Science Practice at ARSENAL ADVISORS discusses the challenges biopharma and medtech organizations are facing as they compete for HCP engagement with MobileLocker’s Chief Revenue Officer Bob Lempke.
We sit down with Hans Kaspersetz of Relevate + Arteric to help us turn data into insights
Frank Dolan spoke with Joe Mullings for this edition of the ARSENAL Leader Lab series. As CEO of the Mullings Group Companies and Chief Vision Officer for MRINetwork, Mullings had extensive knowledge to offer.
The life science industry is rapidly advancing towards digitization. From research and development to marketing, sales, advertising, and distribution, all aspects of the industry are undergoing a significant shift.
Human capital is the most valuable resource for life science organizations. However, ever-changing workforce requirements can be challenging, which the pharma industry can overcome by outsourcing services.
The life science industry often views community engagement in healthcare as an external concern—a matter of marketing, outreach, and education. However, building a community is about reducing the gap between complex medical concepts and customers, with healthcare being the obvious connector.
As part of the ARSENAL Leader Lab, Frank Dolan set out to find the answer by speaking with Joe Mullings, CEO of the Mullings Group Companies and Chief Vision Officer for MRINetwork. Below, you’ll learn about the two questions you should be prepared to ask your interviewer. We hope this helps you during your job search.
Frank Dolan asked Hans Kaspersetz of Arteric to help us identify emerging data techniques that can help biopharma marketers find, connect, and engage customers. The case study will open opportunities you may not have known existed.
They go online to ask for opinions regarding their doctor’s advice. Clearly, patient marketing is more important than ever before. To help discuss what the industry needs to be aware of going forward, Frank Dolan sat down with Paul Murasko, Head of Digital Customer Interaction for Ipsen North America.
Before you can sell someone your product, you want to connect with them. This helps lead to deeper, more lasting customer relationships, which in turn leads to more success for your business.
For many years now, the pharmaceutical industry has used the term “Non-Personal Promotion” to refer to sales and marketing techniques not done face-to-face (i.e. digital marketing efforts). Paul Murasko is unsatisfied with calling this form of promotion ‘non-personal’, though, because “you can start using data to properly send messaging at the right time, at the right place, through the right channel.”
Besides the pressure to maintain lower healthcare costs and increased competition from new entrants, life science companies find it challenging to market themselves and expand their reach.
Getting on the formulary is more difficult than ever before, given the number of new, high-cost drugs that are entering the market. That’s one of the reasons why Frank Dolan sat down with Steve O’Malley, Executive Vice President of Market Access at Two Labs, as part of the Life Science Leader Lab series.
The life science sector is rapidly advancing towards digitization. Most of this transformation has taken place in research and development, but it will expand to other fields like marketing, sales, advertising, and distribution in the coming years.
Now, more than ever, sales force need to be nimble. But not nimble with strategy as much as the tactics. Being able to serve customer face-to-face and, now, virtually is critical to surpass the competition.
The life sciences field is very complicated, but before you can get your product in the hands of patients who need them, you first need to get approved by payers.
There are more than 88 million podcast listeners in the United States, with 32% of them tuning in at least once a month. Since the pandemic, these numbers have increased 42% globally. Podcasts are gaining popularity as an increasing number of users are discovering new content via the new medium. Recording your ideas and knowledge into an easily digestible audio form allows listeners to absorb information on-the-go.
Here are five online tools for marketers in the biotech and life science industry to help you plan and execute future strategies.
The traditional methods of generating revenue in pharmaceutical markets are no longer effective. To deliver positive results for their businesses, the healthcare industry must consider patient loyalty as part of their marketing strategy.
Here are eight strategies to boost virtual sales in the healthcare industry during these unprecedented times:
What Mistakes Do Companies Make When Hiring Talent? Hiring for life sciences companies is more competitive than ever before, which means your hiring strategy needs to be equally competitive. That’s why Frank Dolan sat down with Shawn Kerek, the VP of Executive Search at Taylor Partners, to learn best practices—and things to avoid—to have a…
Catching up with Tamar Frank Dolan, CEO of ARSENAL ADVISORS, caught up with Tamar Thompson, Vice President of Government Affairs at Alexion Pharmaceuticals, at the REIMAGINE BioPharma Summit on February 25, 2021 With so much activity and uncertainty in Washington, Tamar shared her outlook on the issues that the biotech, pharmaceutical, and medtech industries should…
Mastering the Art of Virtual Sales Calls for BioPharma & MedTech The Covid-19 pandemic has changed how we live, and especially how we work. With a majority of the workforce around the world going remote, the pandemic has revealed the cracks in the processes workers and corporations have been using for so many years. It…
4 Myths About the Biopharma Industry Many myths and conspiracy theories surround the pharma sector, from exaggerating production costs to giving the public sector credit for developing medicines. The pharmaceutical market in the U.S. grew at a rate of 4% in 2019, and it’ll be worth $685.45 billion by 2023. With such vast potential in…
Life science conferences and summits provide a unique platform to share ideas and emerging knowledge with the larger medical research community. Most biotech and pharma industry stakeholders share similar goals: reduce the rate of infectious diseases, save patients from life-threatening conditions, find tailored treatments to minimize health risks, combat severe illnesses, and develop tools for…